Harbor Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Harbor Capital Advisors's AMGN Position: Q2 2026 in Review
Harbor Capital Advisors increased its Amgen (AMGN) stake by 0.22% in Q2 2026, buying an estimated $4.45K and bringing the position to 6,049 shares worth $2.19M. The position accounts for 0.15% of the portfolio, ranked #193.
Harbor Capital Advisors first reported a position in AMGN in Q1 2023 and has held it in 10 quarters since. The position peaked at $3.68M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Harbor Capital Advisors held 6,049 shares of Amgen worth $2.19M as of Q2 2026.
- Harbor Capital Advisors bought 13 Amgen shares in Q2 2026, an estimated $4.45K.
- Amgen made up 0.15% of Harbor Capital Advisors's portfolio in Q2 2026, its #193 holding.
- Harbor Capital Advisors first reported a position in Amgen in Q1 2023 and has held it in 10 quarters since.
- Harbor Capital Advisors's Amgen position peaked at $3.68M in Q3 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.